ValbiotisFRA:8JD 62 EV-to-FCF is -2.99 as of Jul. 03, 2026. GuruFocus rates FRA:8JD with a GF Score™ of 62/100 and a GF Value™ of €1.41 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,189 Consumer Packaged Goods companies, Valbiotis ranks worse than 84104.21% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Valbiotis's Enterprise Value is €24.46 Mil.
Valbiotis's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-8.19 Mil. Therefore, Valbiotis's EV-to-FCF for today is -2.99.
The historical rank and industry rank for Valbiotis's EV-to-FCF or its related term are showing as below:
FRA:8JD'
s EV-to-FCF Range Over the Past 10 Years
Min: -7.58 Med: -2.08 Max: 22.04
Current: -3.05
During the past 11 years, the highest EV-to-FCF of Valbiotis was 22.04. The lowest was -7.58. And the median was -2.08.
FRA:8JD's EV-to-FCF is ranked worse than 100% of 1189
companies
in the Consumer Packaged Goods industry
Industry Median: 15.4
vs FRA:8JD: -3.05
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Valbiotis's share price for today is €0.775.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Valbiotis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.486.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Valbiotis EV-to-FCF Related Terms
Valbiotis EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Valbiotis's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Valbiotis's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Valbiotis EV-to-FCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Valbiotis's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Valbiotis's EV-to-FCF falls into.
Valbiotis's current Enterprise Value is €24.46 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Valbiotis's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-8.19 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Valbiotis (FRA:8JD) has a EV-to-FCF of -2.99 as of Jul. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Valbiotis and its competitors. According to the industry distribution chart, Valbiotis ranks #999999 out of 1189 companies in the Consumer Packaged Goods industry.
Is Valbiotis' EV-to-FCF too high?
Valbiotis' current EV-to-FCF is -2.99. Based on the distribution chart, Valbiotis ranks #999999 out of 1189 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Valbiotis has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Valbiotis' EV-to-FCF compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Valbiotis ranks #999999 out of 1189 companies for EV-to-FCF. This places Valbiotis in the lower half of its industry. The industry median EV-to-FCF is 15.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 15.40, based on 1,189 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Valbiotis and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 15.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Valbiotis's current EV-to-FCF is -2.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valbiotis stock overvalued right now?
Based on GuruFocus' analysis, Valbiotis (FRA:8JD) is currently considered Possible Value Trap. The stock's GF Value™ is €1.41, compared to a current price of €0.78 — trading 45% below its estimated fair value. The current EV-to-FCF is -2.99. Valbiotis' overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Valbiotis (FRA:8JD), the current EV-to-FCF is -2.99 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Valbiotis (FRA:8JD) Overvalued in 2026?
Based on GuruFocus' analysis, Valbiotis stock appears to be undervalued.
The current stock price of €0.78 is trading 45% below its estimated GF Value™ of €1.41.
GuruFocus considers Valbiotis to be Possible Value Trap.
Key valuation signals for FRA:8JD:
EV-to-FCF: -2.99
GF Value™: €1.41 vs. price of €0.78 (45% below fair value)
No single metric tells the full story. See the FRA:8JD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.
62GF Score
Get the complete analysis for FRA:8JD
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:8JD has been successfully added to your 
